Orphan Drugs
Journal: International Journal of Science and Research (IJSR) (Vol.8, No. 12)Publication Date: 2019-12-05
Authors : Priya Shaju;
Page : 1349-1355
Keywords : Rare disease; Orphan drugs; ODA;
Abstract
An orphan drug is a pharmaceutical agent that is used to treat a rare medical condition (viz. , Huntington�s disease, myoclonus disease, Tourette syndrome etc. ). They receive little attention from pharmaceutical companies as the small patient population could not justify the huge investment required for drug development. In the last 20 years, orphan drug act has been adopted in several countries around the world (USA, Japan, Australia, and the EU) and has successfully promoted R& D investments to develop new pharmaceutical products for the treatment of rare diseases, but it faces future challenges like returns on the huge R& D costs, funding sources and initiatives for development of orphan drugs.
Other Latest Articles
- The EFL Teachers Approaches in Dealing with At-Risk Students; A Focus on the Technology Use
- Determination of Zinc Levels in Cord Blood and Its Possible Effects on the Fetus
- Standardization, Quality Evaluation and Cost of Production of Cookies Incorporated with Spent Hen Meat Powder
- A Review of Municipal Solid Waste Gasification Technologies for Possible Fixed Bed Hybridization
- Design of a High Selectivity Quadband Bandpass Filter Based on Open Loop Stub Loaded Resonator for UMTS, WLAN, Wimax and ITU Applications
Last modified: 2021-06-28 18:33:10